MEDIROM Healthcare Technologies Inc. (MRM) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
Analysts estimate Earnings Per Share (EPS) of $0.07 and revenue of $8.38B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.19 vs est $0.07 (beat +178.6%). Analyst accuracy: 36%.
MRM Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to MEDIROM Healthcare Technologies Inc. in the past 3 months
EPS Estimates — MRM
36%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.19
vs Est $0.07
▲ 64.1% off
Profitability Outlook
Company is profitable but with thin earnings per share. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — MRM
99%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $8.299B
vs Est $8.377B
▼ 0.9% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
